Actomyosin remodeling regulates biomineral formation, growth and morphology during eukaryote skeletogenesis

  1. Department of Marine Biology, Leon H. Charney School of Marine Sciences, University of Haifa, Haifa 31905, Israel
  2. B CUBE Center for Molecular Bioengineering, Technische Universität Dresden, 01309 Dresden, Germany
  3. Department of Electrical Engineering, Computer Science and Mathematics, Technische Universiteit Delft, Delft 2628CD, Netherlands

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, public reviews, and a provisional response from the authors.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Charles Ettensohn
    Carnegie Mellon University, Pittsburgh, United States of America
  • Senior Editor
    Kathryn Cheah
    University of Hong Kong, Hong Kong, Hong Kong

Reviewer #1 (Public Review):

Using a pharmacological and knock-down approach, the authors could demonstrate that ROCK activity is required for the normal development of the larval skeleton. The presence of ROCK in the pluteus stage depends on the activity of VEGF that is responsible for the formation of the tubular syncytial sheath of the calcifying primary mesenchyme cells in which the skeleton forms. The importance of ROCK in skeleton formation was confirmed in cell culture experiments, demonstrating that ROCK inhibition leads to decreased elongation and abnormal branching of spicules. µCT analyses underline this finding demonstrating that the inhibition of ROCK mainly affects the elongation of spicules while growth in girth is little affected. F-actin labeling experiments could demonstrate that ROCK inhibition interferes with the organization of the actomyosin network in the early phase of skeleton formation, while f-actin organization in the tips of the elongating spicule is unaffected by the pharmacological inhibition of ROCK. Finally, ROCK inhibition strongly affects the expression of major regulatory and calcification-related genes in the calcifying cells. Based on these findings the authors propose a model for the regulatory interaction between the skeletogenic GRN, ROCK, and the f-actin system relevant for skeletogenesis.

I reviewed this paper previously for submission to another Journal. I emphasize again, that this is an interesting and important work that aims to uncover the interaction between the Rho-associated Kinase, ROCK, the actomyosin network, and its relevance for the formation of the calcitic skeleton of the sea urchin larva. I carefully went through the revised manuscript. In their new version, the authors rearranged the figures to provide a more direct comparison between the in vivo and cell culture experiments which mitigates the criticism of collateral effects by the inhibitors on the whole organism. The authors also performed an additional experiment localizing the F-Actin signal in spicules of PMC cell cultures under ROCK inhibition. This experiment strengthens the concept that ROCK activity is important for tip dominance rather than CaCO3 deposition rates. The results section was substantially reorganized and only very minor changes were made to the introduction and discussion.

I think that this work has great potential to provide seminal insights into an understudied aspect of the biomineralization process - the role and regulation of the cytoskeleton in calcifying cells. As I mentioned in my previous review there are some gaps in this work that need to be answered to provide a conclusive dataset on the role of ROCK and the actomyosin system in the mineralization process. The manuscript in its current form provides evidence for the interaction of ROCK with the actomyosin system in the sea urchin larva and that perturbation of this system affects skeletogenesis. However, it is missing an explanation regarding the mechanism by which ROCK affects skeleton formation. No difference in f-actin localization was found at the spicule tips in control and ROCK-inhibited larvae. A slight hint was found in the difference in vesicle size and f-actin organization within calcifying cells, but it remains unresolved if ROCK activity impacts the trafficking of calcification vesicles. The authors provide an interesting discussion on the involvement of f-actin and ROCK on vesicular trafficking, and exocytosis based on existing knowledge from animal and plant models. But for the sea urchin larva, this important link between ROCK, f-actin, and the biomineralization process remains unanswered. In their previous work by Winter et al. 2021, the authors demonstrated excellent technologies to monitor vesicular dynamics in the calcifying cells. This tool would be ideal to investigate the role of ROCK and the actomyosin network on the trafficking dynamics of Ca2+-rich vesicles. These experiments (among others suggested in the following review) may help to uncover the critical mechanism to resolve the missing gap in this manuscript.

Major comments
One MASO led to reduced skeleton formation while the other one additionally induced ectopic branching. How was the optimum concentration for the MASOs determined? Did the authors perform a dose-response curve? What is the reason for this difference? Which of the two MASOs can be validated by reduced ROCK protein abundance? Since the ROCK antibody works, I would like to see a control experiment on Rock protein abundance in control and ROCK MO injected larvae which is the gold-standard for validating the knock-down.

L212 "Together, these measurements show that ROCK is not required for the uptake of calcium into cells." But what about trafficking and exocytosis? As mentioned earlier, I think this is a really important point that needs to be confirmed to understand the function of ROCK in controlling calcification. In their previous study (reference 45) the authors demonstrated that they have superior techniques in measuring vesicle dynamics in vivo. Here an acute treatment with the ROCK inhibitor would be sufficient to test if calcein-positive vesicle motion, including the observed reduction in velocity close to the tissue skeleton interface, is affected by the inhibitor.

Is there a colocalization of ROCK and f-actin in the tips of the spicules? This would support the mechano-sensing-hypothesis by ROCK.

L 283. "F-actin is enriched at the tips of the spicules independently of ROCK activity" The results of this paragraph clearly demonstrate that ROCK inhibition has no effect on the localization of f-actin at the tips of the growing spicules. In addition, the new cell culture experiments underline this observation. Still, the central question that remains is, what is the interaction between ROCK, f-actin, and the mineralization process, that leads to the observed deformations? What does the f-actin signal look like in a branched phenotype or in larvae that failed to develop a skeleton (inhibition from Y20)?

Immunohistochemical analyses on f-actin localization and abundance should be additionally performed with ROCK knock-down phenotypes to confirm the pharmacological inhibition.

L 365 "...supporting its role in mineral deposition..." "...Overall, our studies indicate that ROCK activity....is essential for the formation of the spicule cavity......which could be essential for mineral deposition..." I think the authors need to do a better job in clearly separating between the potential processes impacted by ROCK perturbation. Is it stabilization and mechano-sensing in the spicule tip or the intracellular trafficking and deposition of the ACC? If the dataset does not allow for a definite conclusion, I suggest clearly separating the different possibilities combined with thorough discussion-based findings from other mineralizing systems where the interaction between ROCK and F-actin has been described.

Reviewer #2 (Public Review):

This manuscript reports on the role of Rho-associated coiled-coil kinase (ROCK) in biomineralization of sea urchin larval skeletons. A number of experiments examine the initiation, growth, and patterning of the skeleton in an effort to determine if, and how, ROCK participates in skeletal formation. The authors conclude that ROCK controls the formation, growth, and morphology (patterning) of the skeleton based on a number of inhibition studies. The main target of the experiments is the actomyosin cytoskeleton which has been the focus of many ROCK studies in vertebrates. Based on similar experimental outcomes when comparing the results here with published data from vertebrates, they suggest that ROCK and the actomyosin network operate in a similar way in biomineralization despite independent evolutionary origins of the sea urchin larval skeletons and the skeletons of vertebrates.

My concerns are the interpretation of the experiments. The main overriding concern is a possible over-interpretation of the role of ROCK. In the literature that ROCK participates in many biological processes with a major contribution to the actin cytoskeleton. And when a function is attributed to ROCK, it is usually based on the determination of a protein that is phosphorylated by this kinase. Here that is not the case. The observation here is in most cases stunted growth of the spicule skeleton and some mis-patterning occurs or there is an absence of skeleton if the inhibitor is added prior to initiation of skeletal growth. They state in the abstract that ROCK impairs the organization of F-actin around the spicules. The evidence for that as a direct role is absent. They use morpholino data and ROCK inhibitor data to draw their conclusion. My main concern is the concentration of the inhibitor used since at the high concentrations used, the inhibitor chosen is known to inhibit other kinases as well as ROCK (PKA and PKC). They indicate that this inhibition is specifically in the skeletogenic cells based on the isolation of skeletogenic cells in culture and spicule production either under control or ROCK inhibition and they observe the same - stunting and branching or absence of skeletons if treated before skeletogenesis commences. Again, however, the high concentrations are known to inhibit the other kinases. They use blebbistatin and latrunculin and show that these known inhibitors of actin cytoskeleton lead to abnormal spiculogenesis, This coincidence is suggestive but is not proof that it is ROCK acts on the actomyosin cytoskeleton given the specificity concerns.

Author Response:

Thank you very much for selecting our paper for peer review and for the thorough evaluation of our manuscript. We appreciate your assessment and the reviewers’ comments that value our work and identify important points that will enable us to improve the paper. We are now working on key experiments to further test the hypothesis that ROCK is essential for the formation, growth, and morphology of the sea urchin larval skeleton. We will address the reviewers’ comments in detail in the revised version of the paper that we will submit after completing the experiments, but for now, there are two points we would like to clarify.

We thank the first reviewer for the appreciation of this paper and of our previous work where we studied calcium vesicle dynamics in whole embryos (Winter et al, Plos Com Biol 2021). In Winter et al 2021, we found that the skeleton (spicules) doesn’t grow when the embryos are immobilized in either control or treated embryos. As a consequence, we cannot determine the role of ROCK in vesicle trafficking and exocytosis based on experiments conducted in whole embryos. We are developing an alternative assay for vesicle tracking using cell cultures, but that is beyond the scope of this current work.

As for the second reviewer’s criticism of the usage of Y-27632 to block ROCK activity: The ROCK inhibitor concentrations we used (30-80µM) are similar the those commonly used in mammalian systems and in Drosophila to block ROCK activity, for example: (Becker et al., 2022; Canellas-Socias et al., 2022; Fischer et al., 2009; Kagawa et al., 2022; Segal et al., 2018; Su et al., 2022). The manufactory datasheet indicates that: “Y-27632 dihydrochloride is a selective ROCK inhibitor (Ki values are 0.14-0.22, 0.3, 25, 26 and > 250 μM for ROCK1 (p160 ROCK), ROCK2, PKA, PKC and MLCK respectively)”. That is, the affinities of Y-27632 for ROCK kinases are at least 100 times higher than those for PKC, PKA, and MLCK. Furthermore, these Ki values are based on biochemistry assays where the activity of the inhibitor is tested in-vitro with the purified protein. Therefore, these concentrations are not relevant to cell or embryo cultures where the inhibitor has to penetrate the cells and affect ROCK activity in-vivo. Y-27632 activity was studied both in-vitro and in-vivo in Narumiya, Ishizaki and Ufhata, Methods in Enzymology 2000 (Narumiya et al., 2000). This paper reports similar concentrations to the ones indicated in the manufactory data sheet for the in-vitro experiments, but shows that 10µM concentration or higher are effective in cell cultures. As stated above, we will add additional experimental verifications to the revised version, but even at this stage, the concentrations we used and the agreement between our pharmacological and genetic perturbations suggests that the affected protein is indeed ROCK.

We share the reviewers and editors wish to identify the molecular targets of ROCK and the specific cellular processes that ROCK is involved in, and we are actively working on achieving this goal. However, we believe that this paper is an important step towards illuminating the cellular components that participate in biomineral construction and the feedback between the cellular machinery and gene expression.

Best,

Smadar, in the name of all co-authors.

References:

  • Becker, K.N., Pettee, K.M., Sugrue, A., Reinard, K.A., Schroeder, J.L., Eisenmann, K.M., 2022. The Cytoskeleton Effectors Rho-Kinase (ROCK) and Mammalian Diaphanous-Related (mDia) Formin Have Dynamic Roles in Tumor Microtube Formation in Invasive Glioblastoma Cells. Cells 11.
  • Canellas-Socias, A., Cortina, C., Hernando-Momblona, X., Palomo-Ponce, S., Mulholland, E.J., Turon, G., Mateo, L., Conti, S., Roman, O., Sevillano, M., Slebe, F., Stork, D., Caballe-Mestres, A., Berenguer-Llergo, A., Alvarez-Varela, A., Fenderico, N., Novellasdemunt, L., Jimenez-Gracia, L., Sipka, T., Bardia, L., Lorden, P., Colombelli, J., Heyn, H., Trepat, X., Tejpar, S., Sancho, E., Tauriello, D.V.F., Leedham, S., Attolini, C.S., Batlle, E., 2022. Metastatic recurrence in colorectal cancer arises from residual EMP1(+) cells. Nature 611, 603-613.
  • Fischer, R.S., Gardel, M., Ma, X., Adelstein, R.S., Waterman, C.M., 2009. Local cortical tension by myosin II guides 3D endothelial cell branching. Curr Biol 19, 260-265.
  • Kagawa, H., Javali, A., Khoei, H.H., Sommer, T.M., Sestini, G., Novatchkova, M., Scholte Op Reimer, Y., Castel, G., Bruneau, A., Maenhoudt, N., Lammers, J., Loubersac, S., Freour, T., Vankelecom, H., David, L., Rivron, N., 2022. Human blastoids model blastocyst development and implantation. Nature 601, 600-605.
  • Narumiya, S., Ishizaki, T., Uehata, M., 2000. Use and properties of ROCK-specific inhibitor Y-27632. Methods Enzymol 325, 273-284.
  • Segal, D., Zaritsky, A., Schejter, E.D., Shilo, B.Z., 2018. Feedback inhibition of actin on Rho mediates content release from large secretory vesicles. J Cell Biol 217, 1815-1826.
  • Su, Y., Huang, H., Luo, T., Zheng, Y., Fan, J., Ren, H., Tang, M., Niu, Z., Wang, C., Wang, Y., Zhang, Z., Liang, J., Ruan, B., Gao, L., Chen, Z., Melino, G., Wang, X., Sun, Q., 2022. Cell-in-cell structure mediates in-cell killing suppressed by CD44. Cell Discov 8, 35.
  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation